Clinical Trial Update: Leflunomide in Previously Treated Metastatic Triple Negative Cancers [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update shows completion of a Phase 1/2 study evaluating leflunomide in previously treated metastatic triple-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Leflunomide (Arava) (leflunomide)

Snippet

Sponsor: Joseph Sparano | Conditions: Breast Neoplasms, Breast Diseases | Phase 1, Phase 2 | Status: COMPLETED